Ad-hoc News
29.11.2007
biolitec AG Decides to Raise Cash by Means of Share Capital Increase under Exclusion of Subscription Rights
Jena, November 29, 2007. Today the Executive Board of the company biolitec AG (Frankfurt, Prime Standard: BIB) decided, with the Supervisory Board's consent, to increase the company's share capital from EUR 10,015,000.00 by EUR 1,001,499.00 up to EUR 11,016,499.00, by cash contribution and partly utilizing the approved capital. The capital increase is carried out under exclusion of subscription rights. As Sole Lead Manager ICF Kursmakler AG will offer the new shares with institutional investors in Germany and Europe at a price close to market by means of an accelerated bookbuilding process.
The proceeds from the capital increase are intended for the further expansion of the sales force as well as for financing research and development projects in the future.
No offering:
This announcement does not constitute, or form part of an offer or solicitation of an offer to purchase or subscribe for securities in the United States or any other jurisdiction. The securities referred to herein have not been and will not be registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States, except pursuant to an available exemption from registration. No public offering of securities is being made in the United States.
